Mike Enzi @SenatorEnzi
We are not benefiting from cheaper prescription drug alternatives like biosimilars as much as we should. Biosimilars are one of the ways we can do something about health care costs without just shifting them elsewhere in the system or implementing administrative price controls. — PolitiTweet.org